Kuros Biosciences AG
SIX:KURN
Kuros Biosciences AG
SIX:KURN
Price:
27.78
CHF
4.83%
Market Cap:
CHf1.1B
Relative Value
The Relative Value of one
KURN
stock under the Base Case scenario is
hidden
CHF.
Compared to the current market price of 27.78 CHF,
Kuros Biosciences AG
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
KURN Relative Value
HIDDEN
Multiples Across Competitors
KURN Competitors Multiples
Kuros Biosciences AG Competitors
Kuros Biosciences AG Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CH |
|
Kuros Biosciences AG
SIX:KURN
|
1B CHF | 8.7 | -144.8 | 765.3 | -503.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
415.6B USD | 6.8 | 98.9 | 16.2 | 22.5 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
204.5B USD | 5.5 | 26.4 | 15.1 | 15.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.3B USD | 6.2 | 21.6 | 13.4 | 16.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.7B USD | 10 | 30.5 | 23 | 24 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.6B USD | 5.7 | 18.1 | 13.5 | 15.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69.1B AUD | 3.2 | 35.1 | 11.6 | 14.5 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.9B EUR | 11.3 | 36.3 | 39.6 | 40.4 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
